Aratana Therapeutics Inc’s (PETX) share price has entered into oversold territory with an RSI value of 29.9. The Zacks Consensus Estimate for Aratana for the full year period has improved $1.16 over the past two months to -$8.64 per share. Currently, Aratana has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get in on (PETX) after its recent drop.
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment